Pharmaceutical Products Recalled From The Lebanese Market According To Minister's Decision No.74/1

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 50mg	50mg	Tablet	163,949 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,162,216 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	3,031,709 L.L
C09BX01	TRIPLIXAM	B	Perindopril arginine - 10mg, Indapamide - 2.5mg, Amlodipine - 5mg		Tablet, film coated	1,237,679 L.L
D07CC01	FUCICORT	B	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	376,276 L.L
N04BC09	NEUPRO	B	Rotigotine - 8mg/24h	8mg/24h	Patch	12,394,936 L.L
R03AK10	RELVAR ELLIPTA	B	Vilanterol (trifenatate) - 25mcg/dose, Fluticasone furoate - 200mcg/dose		Inhalation powder	3,928,052 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 100mg	100mg	Suppository	294,302 L.L
C09BX01	TRIPLIXAM	B	Perindopril arginine - 10mg, Indapamide - 2.5mg, Amlodipine - 10mg		Tablet, film coated	1,315,622 L.L
D07CC01	FUCICORT	B	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	501,253 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 20mg	20mg	Tablet	326,608,760 L.L
N02BE01	PANADOL JOINT	B	Paracetamol - 665mg	665mg	Tablet, film coated, prolonged release	291,614 L.L
N06AX16	EFEXOR XR	B	Venlafaxine (HCl) - 150mg	150mg	Capsule, sustained release	817,056 L.L
R03AK10	RELVAR ELLIPTA	B	Vilanterol (trifenatate) - 25mcg/dose, Fluticasone furoate - 100mcg/dose		Inhalation powder	3,928,052 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,162,216 L.L
B01AF01	XARELTO	B	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	4,045,168 L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	79,583,961 L.L
C09BX02	COSYREL	B	Perindopril arginine - 5mg, Bisoprolol fumarate - 5mg		Tablet, film coated, scored	749,864 L.L
J01MA06	NOROXIN	B	Norfloxacin - 400mg	400mg	Tablet, film-scored	574,653 L.L
J07BD52	PRIORIX	B	Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50		Injectable lyophilised powder for solution+diluent	1,142,266 L.L
R03AK12	ZEPHIRUS	B	Salmeterol - 20mcg, Budesonide - 120mcg		Capsule, inhalation	1,412,378 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,162,216 L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	79,583,961 L.L
C09BX02	COSYREL	B	Perindopril arginine - 10mg, Bisoprolol fumarate - 5mg		Tablet, film coated, scored	749,864 L.L
J01MA12	TAVANIC 500MG	B	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	1,988,887 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L

Pharmaceutical Products Recalled from the Lebanese Market according to Minister's Decision No.74/1 Date 15/1/2019